Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis
NCT02716103
·
clinicaltrials.gov ↗
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Amyloidosis
Interventions
OTHER:
blood collection
OTHER:
bone marrow collection
Sponsor
Boston Medical Center